ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,389Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 1000

$774K Total Retail Price of All Prescriptions

Rank: 116 out of 1000

683 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 683 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

22% of this provider’s 683 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

4% of this provider’s 11,472 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,024 529 S3 1 1
SIMVASTATIN 892 593 2 3
OMEPRAZOLE 853 461 3 2
LISINOPRIL 788 531 4 5
METFORMIN HCL 540 300 5 8
MELOXICAM 429 274 6 14
HYDROCHLOROTHIAZIDE 413 260 7 9
CARVEDILOL 412 287 8 15
AMLODIPINE BESYLATE 407 275 9 6
FUROSEMIDE 384 219 10 7
ATENOLOL 349 215 11 24
LEVOTHYROXINE SODIUM 336 232 12 4
CITALOPRAM HBR 294 127 13 17
ZOLPIDEM TARTRATE 278 130 14 16
GABAPENTIN 271 127 15 11
TRAMADOL HCL 218 122 16 13
POTASSIUM CHLORIDE 216 130 17 10
WARFARIN SODIUM 215 166 18 22
GLYBURIDE-METFORMIN HCL 214 152 R 19 121
RANITIDINE HCL 203 131 20 37
ATORVASTATIN CALCIUM 198 108 21 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 193 100 22 20
NEXIUM 192 95 23 23
FENOFIBRATE 187 131 24 55
BUSPIRONE HCL 186 106 25 110
CYCLOBENZAPRINE HCL 181 63 R 26 39
TAMSULOSIN HCL 180 130 27 33
DOXYCYCLINE HYCLATE 179 92 28 97
PRAVASTATIN SODIUM 167 123 29 12
PANTOPRAZOLE SODIUM 165 120 30 28
CRESTOR 158 96 31 30
ALENDRONATE SODIUM 154 130 32 57
TIZANIDINE HCL 148 56 33 76
ETODOLAC 147 96 34 152
METOPROLOL TARTRATE 145 103 35 19
CLOPIDOGREL 139 81 36 35
SERTRALINE HCL 136 95 37 26
LOSARTAN POTASSIUM 136 100 37 25
METOPROLOL SUCCINATE 116 79 39 21
PLAVIX 113 83 40 49
VENTOLIN HFA 112 53 41 83
SULFAMETHOXAZOLE-TRIMETHOPRIM 108 66 42 70
SPIRONOLACTONE 107 60 43 78
ALLOPURINOL 107 78 43 31
DONEPEZIL HCL 105 104 45 32
BENAZEPRIL HCL 102 58 46 61
METOCLOPRAMIDE HCL 95 30 47 99
TRIAMTERENE-HCTZ 95 51 47 48
LYRICA 90 46 49 47
GLIPIZIDE ER 89 62 50 106
PREDNISONE 88 49 51 42
GLIPIZIDE 88 66 51 62
CARISOPRODOL 88 22 R 51 72
MECLIZINE HCL 88 78 51 80
LOVASTATIN 86 31 55 41
AMLODIPINE BESYLATE-BENAZEPRIL 85 72 56 59
CLONIDINE HCL 85 24 56 27
SINGULAIR 83 37 58 84
FLUOXETINE HCL 83 38 58 51
CELEBREX 80 58 60 98
DIOVAN 79 41 61 67
CEPHALEXIN 79 45 61 90
VERAPAMIL ER 76 47 63 86
GLIMEPIRIDE 75 43 64 34
ACTOS 75 44 64 119
NAPROXEN 72 37 66 81
METFORMIN HCL ER 71 28 67 44
PREMARIN 69 37 R 68 109
TRAZODONE HCL 67 36 69 29
ROPINIROLE HCL 65 41 70 82
DIGOXIN 65 54 70 52
PAROXETINE HCL 64 29 72 63
LANTUS SOLOSTAR 64 0 72 120
AMITRIPTYLINE HCL 64 26 R 72 45
ENALAPRIL MALEATE 63 29 75 58
FENTANYL 60 32 S2 76 100
ADVAIR DISKUS 57 28 77 65
GLYBURIDE 56 23 R 78 92
TRICOR 55 39 79 141
IBUPROFEN 54 29 80 94
FLUTICASONE PROPIONATE 53 25 81 40
PROMETHAZINE HCL 50 28 R 82 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.